Eli Lilly

LLY · New York Stock Exchange · Health Care

☆ Follow

Shareholder advocacy aimed at Eli Lilly

2 recorded campaigns from 2 organizations.

Trinity Health · 2024
Trinity Health at Eli Lilly
Set up and report on a process for weighing how stretching out patent protection affects patients' ability to get medicines, before applying for follow-on patents.
Source
PETA · 2019 · Filed a resolution
Filed a forced-swim-test resolution at Eli Lilly, went to a vote
Same forced-swim-test ask as at BMS/AbbVie/Pfizer. Scheduled for a shareholder vote on May 6, 2019; vote percentage not confirmed in sources reviewed.
Source

How organizations asked shareholders to vote

Positions these organizations published themselves, each linked to where they published it. Nothing here is our view of how to vote.

2026

Organization	Item	Asks shareholders to vote	Source
Sierra Club	Shareholder resolution: Lobbying Expenditures Disclosure	For	Published position

What shareholders voted on

From Eli Lilly’s own filings with the SEC. Support is the share of votes cast for and against, so abstentions and broker non-votes are not counted in it.

2026

Item	Kind	Asked for by	Support	Outcome
F) By the following vote, a shareholder proposal requesting the adoption of a policy and amendment to the bylaws to require an independent board chair	Shareholder proposal	Mercy Investment Services	33.7%	Failed
G) By the following vote, a shareholder proposal to prepare an annual lobbying report	Shareholder proposal	CommonSpirit Health	14.9%	Failed
B) By the following vote, the shareholders approved, on an advisory basis, the compensation paid to the Company's named executive officers	Company proposal		96%	Passed
The shareholders voted as follows	Company proposal		87.2%	Passed
The shareholders voted as follows	Company proposal		87.1%	Passed
C) The appointment of Ernst & Young LLP as the Company's independent auditor for 2026	Auditor		94.9%	Passed
Election of Carolyn Bertozzi	Director		99.8%	Passed
Election of Jon Moeller	Director		98.2%	Passed
Election of David Ricks	Director		96.2%	Passed
Election of William Kaelin, Jr.	Director		95.1%	Passed

2025

Item	Kind	Support	Outcome
B) By the following vote, the shareholders approved, on an advisory basis, the compensation paid to the Company's named executive officers	Company proposal	96.3%	Passed
The shareholders voted as follows	Company proposal	86.7%	Passed
The shareholders voted as follows	Company proposal	86.3%	Passed
C) The appointment of Ernst & Young LLP as the Company's independent auditor for 2025	Auditor	95.2%	Passed
Election of Kimberly Johnson	Director	99.5%	Passed
Election of Mary Lynne Hedley	Director	99.2%	Passed
Election of Juan Luciano	Director	95.6%	Passed
Election of Ralph Alvarez	Director	95.2%	Passed

2024

Item	Kind	Asked for by	Support	Outcome
F) By the following vote, a shareholder proposal requesting publication of an annual report disclosing lobbying activities	Shareholder proposal		25.5%	Failed
G) By the following vote, a shareholder proposal requesting a report on the effectiveness of the Company's diversity, equity, and inclusion efforts	Shareholder proposal		23.8%	Failed
I) By the following vote, a shareholder proposal for the Company to adopt a comprehensive human rights policy	Shareholder proposal	CommonSpirit Health	10%	Failed
H) By the following vote, a shareholder proposal requesting to establish and report on a process by which the impact of extended patent exclusivities on product access would be considered in deciding whether to apply for secondary and tertiary patents	Shareholder proposal	Trinity Health	8.9%	Failed
Katherine Baicker, Ph.D	Company proposal		99.4%	Passed
B) By the following vote, the shareholders approved, on an advisory basis, the compensation paid to the Company's named executive officers	Company proposal		95%	Passed
The shareholders voted as follows	Company proposal		86.2%	Passed
The shareholders voted as follows	Company proposal		86%	Passed
C) The appointment of Ernst & Young LLP as the Company's independent auditor for 2024	Auditor		95.8%	Passed
Election of Gabrielle Sulzberger	Director		98.1%	Passed
Election of Jamere Jackson	Director		97.8%	Passed
Election of J. Erik Fyrwald	Director		91.4%	Passed

2023

Item	Kind	Asked for by	Support	Outcome
H) By the following vote, a shareholder proposal to eliminate the supermajority voting requirements in the Articles	Shareholder proposal	John Chevedden	40.7%	Failed
G) By the following vote, a shareholder proposal requesting publication of an annual report disclosing lobbying activities	Shareholder proposal		31.4%	Failed
L) By the following vote, a shareholder proposal requesting a report on the effectiveness of the Company's diversity, equity, and inclusion efforts	Shareholder proposal		27.1%	Failed
K) By the following vote, a shareholder proposal requesting to publish a third-party review of lobbying activities and alignment with public policy positions and statements	Shareholder proposal		22.5%	Failed
I) By the following vote, a shareholder proposal requesting to establish and report on a process by which the impact of extended patent exclusivities on product access would be considered in deciding whether to apply for secondary and tertiary patents	Shareholder proposal	Trinity Health	10.4%	Failed
M) By the following vote, a shareholder proposal to adopt a policy to require certain third-party organizations to annually report expenditures for political activities before Lilly contributes to such organization	Shareholder proposal		4.1%	Failed
J) By the following vote, a shareholder proposal requesting a report on risks of supporting abortion	Shareholder proposal		1.9%	Failed
Marschall S. Runge, M.D., Ph.D	Company proposal		99.6%	Passed
William G. Kaelin, Jr., M.D	Company proposal		98.2%	Passed
Karen Walker	Company proposal		97.3%	Passed
David A. Ricks	Company proposal		95.9%	Passed
B) By the following vote, the shareholders approved, on an advisory basis, the compensation paid to the Company's named executive officers	Company proposal		95.8%	Passed
The shareholders voted as follows	Company proposal		86%	Passed
The shareholders voted as follows	Company proposal		85.4%	Passed
D) The appointment of Ernst & Young LLP as the Company's independent auditor for 2023	Auditor		96.2%	Passed

2022

Item	Kind	Asked for by	Support	Outcome
H) By the following vote, a shareholder proposal requesting to publish an annual report disclosing lobbying activities	Shareholder proposal		37%	Failed
G) By the following vote, a shareholder proposal requesting to amend the Bylaws to require an independent board chair	Shareholder proposal	Legal & General Investment Management America	34.5%	Failed
I) By the following vote, a shareholder proposal requesting to disclose lobbying activities and alignment with public policy positions and statements	Shareholder proposal		34%	Failed
J) By the following vote, a shareholder proposal requesting to report oversight of risks related to anticompetitive pricing strategies	Shareholder proposal	Trinity Health	22.8%	Failed
B) By the following vote, the shareholders approved, on an advisory basis, the compensation paid to the Company's named executive officers	Company proposal		94.4%	Passed
The shareholders voted as follows	Company proposal		85.5%	Passed
The shareholders voted as follows	Company proposal		84.8%	Passed
The shareholders voted as follows	Company proposal		84.7%	Passed
C) The appointment of Ernst & Young LLP as the Company's independent auditor for 2022	Auditor		96.2%	Passed
Election of Kimberly H. Johnson	Director		99.5%	Passed
Election of Juan R. Luciano	Director		96.4%	Passed
Election of Ralph Alvarez	Director		95.8%	Passed

2021

Item	Kind	Asked for by	Support	Outcome
F)By the following vote, a shareholder proposal requesting to disclose direct and indirect lobbying activities and expenditures	Shareholder proposal		48.2%	Failed
I)By the following vote, a shareholder proposal requesting to disclose clawbacks on executive incentive compensation due to misconduct	Shareholder proposal	Trinity Health	40.9%	Failed
G)By the following vote, a shareholder proposal requesting to amend the bylaws to require an independent board chair	Shareholder proposal	Retiree Medical Benefits Trust	36.3%	Failed
H)By the following vote, a shareholder proposal requesting the implementation of a bonus deferral policy	Shareholder proposal		31.3%	Failed
Katherine Baicker, Ph.D	Company proposal		99.5%	Passed
B)By the following vote, the shareholders approved, on an advisory basis, the compensation paid to the Company's named executive officers	Company proposal		95.7%	Passed
The shareholders voted as follows	Company proposal		85.1%	Passed
The shareholders voted as follows	Company proposal		85%	Passed
C)The appointment of Ernst & Young as the Company's independent auditor for 2021	Auditor		96.1%	Passed
Election of Gabrielle Sulzberger	Director		99.2%	Passed
Election of J. Erik Fyrwald	Director		93.1%	Passed
Election of Jamere Jackson	Director		88.5%	Passed
Election of Jackson P. Tai	Director		78.4%	Passed

2020

Item	Kind	Asked for by	Support	Outcome
L)By the following vote, a shareholder proposal requesting board adopt a policy disclosing clawbacks on executive incentive compensation due to misconduct	Shareholder proposal	Trinity Health	35.1%	Failed
H)By the following vote, a shareholder proposal requesting to amend the bylaws to require an independent board chair	Shareholder proposal	Independent Board Chair Daughters of Charity	33.9%	Failed
K)By the following vote, a shareholder proposal requesting the implementation of a bonus deferral policy	Shareholder proposal	Retiree Medical Benefits Trust	31.2%	Failed
F)By the following vote, a shareholder proposal requesting a report regarding direct and indirect lobbying activities and expenditures	Shareholder proposal		29.7%	Failed
J)By the following vote, a shareholder proposal requesting to publish feasibility report on incorporating public concern over drug prices into senior executive compensation arrangements	Shareholder proposal	Mercy Investment Services	24.5%	Failed
G)By the following vote, a shareholder proposal requesting a report on the effectiveness of the forced swim test	Shareholder proposal		3.4%	Failed
I)By the following vote, a shareholder proposal requesting disclosures of specific minimum qualifications and board nominee skills, experience, and ideological perspective	Shareholder proposal		1%	Failed
B)By the following vote, the shareholders approved an advisory vote on compensation paid to our named executive officers	Say on pay		96.9%	Passed
William G. Kaelin, Jr., M.D	Company proposal		99.6%	Passed
The shareholders voted as follows	Company proposal		84.5%	Passed
The shareholders voted as follows	Company proposal		84.5%	Passed
C)The appointment of Ernst & Young as our principal independent auditor for the fiscal year ended December 31, 2020	Auditor		96.4%	Passed
Election of Karen Walker	Director		99.6%	Passed
Election of Marschall S. Runge	Director		99.6%	Passed
Election of David A. Ricks	Director		96.3%	Passed
Election of Michael L. Eskew	Director		79.6%	Passed

2019

Item	Kind	Support	Outcome
F)By the following vote, a shareholder proposal requesting a report regarding direct and indirect political contributions	Shareholder proposal	26.5%	Failed
B)By the following vote, the shareholders approved an advisory vote on compensation paid to our named executive officers	Say on pay	97.8%	Passed
The shareholders voted as follows	Company proposal	84.8%	Passed
The shareholders voted as follows	Company proposal	84.6%	Passed
Carolyn R. Bertozzi, Ph.D	Company proposal	80.7%	Passed
C)The appointment of Ernst & Young as our principal independent auditor for the fiscal year ended December 31, 2019	Auditor	97.4%	Passed
Election of Ralph Alvarez	Director	80.6%	Passed
Election of Juan R. Luciano	Director	80%	Passed
Election of Kathi P. Seifert	Director	79.7%	Passed

2018

Item	Kind	Asked for by	Support	Outcome
H)By the following vote, a shareholder proposal requesting a report regarding direct and indirect political contributions	Shareholder proposal		20.1%	Failed
J)By the following vote, a shareholder proposal requesting a report on the extent to which risks related to public concern over drug pricing strategies are integrated into incentive compensation arrangements	Shareholder proposal	Mercy Investment Services	17.8%	Failed
I)By the following vote, a shareholder proposal requesting a report on policies and practices regarding contract animal laboratories	Shareholder proposal		3.2%	Failed
G)By the following vote, a shareholder proposal seeking support for the descheduling of cannibas	Shareholder proposal		1.6%	Failed
B)By the following vote, the shareholders approved an advisory vote on compensation paid to named executive officers	Say on pay		97.2%	Passed
Katherine Baicker, Ph.D	Company proposal		99.3%	Passed
F)By the following vote, the shareholders approved the Amended and Restated 2002 Lilly Stock Plan	Company proposal		95.9%	Passed
The shareholders voted as follows	Company proposal		83.7%	Passed
The shareholders voted as follows	Company proposal		83.6%	Passed
C)The appointment of Ernst & Young as our principal independent auditor	Auditor		97.8%	Passed
Election of Jamere Jackson	Director		99.3%	Passed
Election of J. Erik Fyrwald	Director		99.1%	Passed
Election of Jackson P. Tai	Director		99%	Passed
Election of Ellen R. Marram	Director		80.9%	Passed

Proxy statements and vote results

Straight from Eli Lilly’s own SEC filings. The proxy statement lists what shareholders were asked to vote on; the 8-K certifies how the vote went.

Year	Filing	Filed
2026	Vote results	2026-05-07
2026	Proxy statement	2026-03-20
2025	Vote results	2025-05-08
2025	Proxy statement	2025-03-21
2024	Vote results	2024-05-09
2024	Proxy statement	2024-03-22
2023	Vote results	2023-05-04
2023	Proxy statement	2023-03-17
2022	Vote results	2022-05-04
2022	Proxy statement	2022-03-18
2021	Vote results	2021-05-05
2021	Proxy statement	2021-03-19
2020	Vote results	2020-05-05
2020	Proxy statement	2020-03-20
2019	Vote results	2019-05-08
2019	Proxy statement	2019-03-22
2018	Vote results	2018-05-08
2018	Proxy statement	2018-03-19

Do you represent Eli Lilly? Claim this profile to respond to the campaigns listed here.

← All companies